BZD immunoassays are limited by high cutoff values and or inability to detect conjugated metabolites most immunoassays detect free or nonconjugated oxazepam or nordiazepam forms common metabolites of several BZDs

By rray, 4 April, 2024
Exclude Patient Type Detail Header
No
Footnote
<sup>1</sup> Moeller KE, et al. Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens. <i>Mayo Clin Proc.</i> 2017 May;92(5):774-796. <a href=https://www.mayoclinicproceedings.org/action/showPdf?pii=S0025-6196%2816%2930825-4><u>Free, full-text PDF</u></a>
Detail Type
Text
Patient Type Detail Header (Long)
BZD immunoassays are limited by high cutoff values and/or inability to detect conjugated metabolites; most immunoassays detect free or nonconjugated oxazepam or nordiazepam forms (common metabolites of several BZDs).